Cost-effectiveness of routine measuring of serum drug concentrations and anti-drug antibodies in treatment of rheumatoid arthritis patients with TNF-α blockers

por Laine, Juha, Jokiranta, T Sakari, Eklund, Kari K, Väkeväinen, Merja, Puolakka, Kari
Publicado 2016

Health‐related quality of life among transthyretin amyloid cardiomyopathy patients

por Eldhagen, Per, Lehtonen, Jukka, Gude, Einar, Gustafsson, Finn, Bagger‐Bahnsen, Anne, Vakevainen, Merja, Pilgaard, Trine, Wedell‐Wedellsborg, Dorte, Poulsen, Steen Hvitfeldt
Publicado 2023

Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden

por Lauppe, Rosa Elisabeth, Liseth Hansen, Johan, Gerdesköld, Christian, Rozenbaum, Mark H, Strand, Anne Mette, Vakevainen, Merja, Kuusisto, Johanna, Gude, Einar, Gustafsson, Finn, Smith, J Gustav
Publicado 2021

Healthcare resource use of patients with transthyretin amyloid cardiomyopathy

por Lauppe, Rosa, Liseth Hansen, Johan, Fornwall, Anna, Johansson, Katarina, Rozenbaum, Mark H., Strand, Anne Mette, Vakevainen, Merja, Kuusisto, Johanna, Gude, Einar, Smith, J. Gustav, Gustafsson, Finn
Publicado 2022

Prevalence, characteristics, and mortality of patients with transthyretin amyloid cardiomyopathy in the Nordic countries

por Lauppe, Rosa, Liseth Hansen, Johan, Fornwall, Anna, Johansson, Katarina, Rozenbaum, Mark H., Strand, Anne Mette, Väkeväinen, Merja, Kuusisto, Johanna, Gude, Einar, Smith, J. Gustav, Gustafsson, Finn
Publicado 2022